Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CHE
CHE logo

CHE Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
384.285
Open
378.040
VWAP
381.06
Vol
154.81K
Mkt Cap
5.60B
Low
376.020
Amount
58.99M
EV/EBITDA(TTM)
13.01
Total Shares
14.61M
EV
5.46B
EV/OCF(TTM)
14.05
P/S(TTM)
2.16
Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company's segment includes VITAS and the Roto-Rooter. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. The Company's water restoration services involve the remediation of water and humidity after a flood and are provided to both commercial and residential customers.
Show More

Events Timeline

(ET)
2026-04-01
10:30:00
Roto-Rooter Acquires Franchises in San Francisco and Fort Worth for $20.6M
select
2026-02-25 (ET)
2026-02-25
17:00:00
Q4 Revenue at $639.3M, Below Consensus of $659.09M
select
2026-02-25
17:00:00
VITAS 2026 Revenue Expected to Increase 5.5%-6.5%
select
2026-02-13 (ET)
2026-02-13
13:30:00
Chemed Corporation Authorizes Additional $300M Stock Repurchase
select

News

Newsfilter
9.5
04-01Newsfilter
Chemed Corporation to Release Q1 2026 Financial Results on April 23
  • Earnings Release Schedule: Chemed Corporation announced it will release its financial results for Q1 2026 on April 23, 2026, after market close, demonstrating the company's commitment to transparency and investor communication.
  • Conference Call Details: The company will host a conference call on April 24, 2026, at 10 a.m. ET to discuss quarterly results and provide business updates, aiming to bolster investor confidence in the company's future prospects.
  • Participation Options: Investors can access the live webcast of the conference call through the investor relations section of Chemed's website, offering multiple participation methods to ensure broad dissemination of information.
  • Caution on Forward-Looking Statements: Chemed's press release highlights that all forward-looking statements are based on current information, cautioning investors about inherent risks and the potential for actual results to differ materially from expectations, reflecting the company's cautious approach to future uncertainties.
Newsfilter
8.5
04-01Newsfilter
Roto-Rooter Acquires Franchises in San Francisco and Fort Worth
  • Acquisition Overview: On March 31, Roto-Rooter Services Company announced the acquisition of franchises and assets in San Francisco, California, and Fort Worth, Texas, for a combined purchase price of approximately $20.6 million, indicating the company's proactive strategy to expand its market share.
  • Market Coverage Enhancement: The acquired Roto-Rooter locations serve a population of about 3.3 million people, significantly increasing the company's penetration in key markets and enhancing its competitive edge in plumbing and drain cleaning services.
  • Clear Strategic Goals: This acquisition is part of Roto-Rooter's ongoing strategy to acquire franchises aimed at boosting productivity and profitability, reflecting the company's confidence in future growth prospects.
  • Company Background: Chemed Corporation, listed on the New York Stock Exchange, operates two wholly owned subsidiaries: VITAS Healthcare, the largest provider of end-of-life hospice care in the U.S., and Roto-Rooter, the leading provider of plumbing and drain cleaning services.
NASDAQ.COM
4.5
02-27NASDAQ.COM
US Stocks Close Mixed: Dow Rises Slightly, Nasdaq Declines
  • Mixed Market Performance: On Thursday, the S&P 500 Index fell by 0.54% and the Nasdaq 100 Index declined by 1.16%, while the Dow Jones Industrial Average rose slightly by 0.03%, indicating a divergence in market sentiment, particularly under pressure from tech stocks.
  • Nvidia Earnings Impact: Nvidia reported Q4 revenue of $62.3 billion, exceeding expectations, yet its stock dropped over 5% due to uncertainties regarding the Chinese market, reflecting investor concerns about an overheated AI economy that could affect related chipmakers' performance.
  • Labor Market Signals: Initial jobless claims in the US rose by 4,000 to 212,000, lower than the expected 216,000, indicating resilience in the labor market, which may provide support for the stock market, especially amid potential interest rate cuts by the Fed.
  • Geopolitical Risks Intensify: President Trump threatened military action against Iran, heightening market uncertainty; although there are signs of progress in US-Iran nuclear negotiations, geopolitical risks remain a focal point for investors and could negatively impact the stock market.
Globenewswire
7.0
02-26Globenewswire
Investigation into Chemed Corporation Investor Claims
  • Earnings Miss: Chemed Corporation reported its Q4 2025 financial results on February 26, 2026, revealing adjusted earnings per share of $6.42 and revenue of $639.3 million, which fell short of consensus estimates by approximately $0.61 and $19.8 million, indicating potential profitability challenges that could undermine investor confidence going forward.
  • Stock Price Decline: Following the earnings report, Chemed's shares experienced a decline on February 26, 2026, as investor concerns about the company's future performance intensified, potentially prompting more investors to seek legal recourse to recover their losses.
  • Legal Investigation Initiated: Johnson Fistel, PLLP is investigating whether Chemed's executives violated federal securities laws, and if findings indicate wrongdoing, the company may face increased legal liabilities and financial repercussions.
  • Investor Rights Protection: Johnson Fistel, PLLP, a recognized shareholder rights law firm, has successfully recovered approximately $90.725 million for clients, demonstrating its effectiveness in advocating for investor rights, which may encourage more affected investors to participate in claims.
seekingalpha
9.5
02-26seekingalpha
Chemed Corporation Q4 2025 Earnings Call Insights
  • VITAS Admissions Growth: In Q4 2025, VITAS admissions reached 17,419, marking a 6% increase from the same period in 2024, indicating positive progress in patient recruitment that is expected to lay the groundwork for future revenue growth.
  • Financial Performance Overview: VITAS reported net revenue of $418.8 million in Q4 2025, a 1.9% year-over-year increase, but adjusted EBITDA was $91.6 million, down 1.7% year-over-year, highlighting challenges in balancing cost control with revenue growth.
  • Roto-Rooter Revenue Decline: Roto-Rooter experienced a 3.7% revenue decline in Q4 2025, despite a 1.6% increase in commercial revenue, with residential revenue down 3.1%, reflecting the impact of intensified market competition and fluctuating service demand.
  • Future Outlook and Strategy: Management anticipates 2026 will be a transition year, with VITAS revenue projected to grow by 5.5% to 6.5%, while Roto-Rooter is expected to achieve revenue growth of 3% to 3.5%, demonstrating the company's confidence in restoring growth moving forward.
seekingalpha
9.5
02-26seekingalpha
Chemed Shares Hit 52-Week Low After Q4 Earnings Miss
  • Disappointing Earnings: Chemed reported Q4 2025 financials with adjusted EPS of $6.42 and revenue of $639.3 million, missing consensus estimates by $0.61 and $19.8 million, indicating pressure on the company's profitability.
  • Decline in Roto-Rooter Segment: The Roto-Rooter segment saw a ~4% year-over-year revenue drop to $220.6 million, reflecting ongoing challenges in plumbing and cleaning services in both U.S. and international markets, impacting overall performance.
  • Analyst Downgrade: Bank of America downgraded Chemed from Buy to Neutral and lowered the price target from $595 to $450, primarily due to Roto-Rooter's EBITDA contracting for three consecutive years, leading to cautious expectations for 2026 guidance.
  • Stable Growth in Vitas Segment: Despite challenges in Roto-Rooter, the Vitas segment achieved approximately 2% year-over-year growth, reaching $418.8 million, with analysts suggesting its relatively stable growth could offset the weaknesses in Roto-Rooter.
Wall Street analysts forecast CHE stock price to rise
3 Analyst Rating
Wall Street analysts forecast CHE stock price to rise
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
475.00
Averages
547.33
High
595.00
Current: 0.000
sliders
Low
475.00
Averages
547.33
High
595.00
Oppenheimer
Oppenheimer
maintain
$500
AI Analysis
2026-03-31
Reason
Oppenheimer
Oppenheimer
Price Target
$500
AI Analysis
2026-03-31
maintain
Reason
Oppenheimer still believes Chemed can unlock Roto-Rooter's value operationally. However, it makes sense to looking at the value of the two companies separately given their lack of synergies and changes to the business, the analyst tells investors in a research note. Oppenheimer applied a 12-18 times multiple on the Roto-Rooter business, equating to $2.3B to $3.5B. Potential value can be unlocked by splitting up the companies, contends the firm. Its analysis puts the total value of Chemed at a $5.6B to $7.8B enterprise value, which translates to $426-$588 per share, or upside potential of 16%-59% from current levels. As such, the analyst recommends being long-term buyer of the stock. Oppenheimer has an Outperform rating on Chemed with a $500 price target. The stock in morning trading is up 1% to $378.27.
Oppenheimer
Michael Wiederhorn
Outperform
to
NULL
downgrade
$580 -> $500
2026-02-27
Reason
Oppenheimer
Michael Wiederhorn
Price Target
$580 -> $500
2026-02-27
downgrade
Outperform
to
NULL
Reason
Oppenheimer analyst Michael Wiederhorn lowered the firm's price target on Chemed to $500 from $580 and keeps an Outperform rating on the shares. The firm notes Chemed reported a Q4 miss, with one-third due to Vitas and two-thirds due to Roto-Rooter. However, Vitas has already created cap buffer in Florida, and is currently working through the related mix-pressures. While Oppenheimer sees long-term value creation opportunity in the consolidated portfolio following this earnings/outlook/pullback, but argues that, if necessary, there is an opportunity to unlock value by breaking up the company.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CHE
Unlock Now

Valuation Metrics

The current forward P/E ratio for Chemed Corp (CHE.N) is 15.92, compared to its 5-year average forward P/E of 23.50. For a more detailed relative valuation and DCF analysis to assess Chemed Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
23.50
Current PE
15.92
Overvalued PE
26.14
Undervalued PE
20.86

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
15.87
Current EV/EBITDA
9.84
Overvalued EV/EBITDA
17.60
Undervalued EV/EBITDA
14.14

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
3.23
Current PS
1.83
Overvalued PS
3.68
Undervalued PS
2.77

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

current bullish rsi divergences
Intellectia · 213 candidates
Rsi Category: oversold
Ticker
Name
Market Cap$
top bottom
NVO logo
NVO
Novo Nordisk A/S
170.38B
MELI logo
MELI
MercadoLibre Inc
89.62B
NTES logo
NTES
NetEase Inc
73.21B
ET logo
ET
Energy Transfer LP
63.96B
BIDU logo
BIDU
Baidu Inc
45.60B
TCOM logo
TCOM
Trip.com Group Ltd
35.00B
for a binnger
Intellectia · 22 candidates
Beta: LowRiskDebt Equity: <= 1Weekly Average Turnover: >= 1,000,000Annual Eps Yoy Growth: >= 0.0%Annual Revenue Yoy Growth: >= 0.0%
Ticker
Name
Market Cap$
top bottom
TW logo
TW
Tradeweb Markets Inc
24.53B
ERIE logo
ERIE
Erie Indemnity Co
14.64B
JKHY logo
JKHY
Jack Henry & Associates Inc
13.59B
DT logo
DT
Dynatrace Inc
11.88B
EPAM logo
EPAM
Epam Systems Inc
11.76B
NYT logo
NYT
New York Times Co
11.51B

Whales Holding CHE

C
Copeland Capital Management, LLC
Holding
CHE
+6.42%
3M Return
A
Aptus Capital Advisors, LLC
Holding
CHE
+5.65%
3M Return
Q
Quantex AG
Holding
CHE
+5.33%
3M Return
A
Aristotle Capital Boston, LLC
Holding
CHE
+4.18%
3M Return
I
Integrated Wealth Concepts LLC
Holding
CHE
+4.15%
3M Return
B
Bridges Investment Management Inc
Holding
CHE
+2.18%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Chemed Corp (CHE) stock price today?

The current price of CHE is 382.88 USD — it has increased 1.4

What is Chemed Corp (CHE)'s business?

Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company's segment includes VITAS and the Roto-Rooter. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. The Company's water restoration services involve the remediation of water and humidity after a flood and are provided to both commercial and residential customers.

What is the price predicton of CHE Stock?

Wall Street analysts forecast CHE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CHE is547.33 USD with a low forecast of 475.00 USD and a high forecast of 595.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Chemed Corp (CHE)'s revenue for the last quarter?

Chemed Corp revenue for the last quarter amounts to 639.34M USD, decreased -0.10

What is Chemed Corp (CHE)'s earnings per share (EPS) for the last quarter?

Chemed Corp. EPS for the last quarter amounts to 5.49 USD, decreased -8.96

How many employees does Chemed Corp (CHE). have?

Chemed Corp (CHE) has 15811 emplpoyees as of April 17 2026.

What is Chemed Corp (CHE) market cap?

Today CHE has the market capitalization of 5.60B USD.